Decibel FY22 Revenue Grows 51% To $58.5M, What About Net Loss?
Decibel Cannabis Company Inc. (OTCQB: DBCCF) (TSXV:DB) achieved record net revenue of CA$79.3 million ($58.5 million) in 2022, an increase of 51% compared to C
SNDL FY22 Revenue Grows 1170% To $525.8M, Here Is What You Need To Know
SNDL Inc. (NASDAQ: SNDL) released its financial and operational results for the full year and fourth quarter ended December 31, 2022, revealing record net revenue of CA$712.2 million ($525.8 million), an increase of 1170% over
Agrify Stock Dips After Accounting Errors Are Discovered In Financial Statements
Agrify Corporation (NASDAQ: AGFY) stock plummeted 30% on April 19, just days after a regulatory filing revealed that the compan
Red Light Holland Receives Certificate Of Analysis For Their Dehydrated Homogenized Natural Psilocybin Aimed For Distribution In Australasia
Red Light Holland Corp. (CSE:TRIP) (FSE:4YX) (OTCQB: TRUFF) announced updates regarding its manufacturing plans to create homogenized natural psilocybin microdosing capsules.
SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression
SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that as part of its ongoing collaboration with Clearmind Medicine Inc. (NASDAQ:
Lifeist Secures $166K Via Private Placement
Lifeist Wellness Inc. (OTCQB:LFSWF) (TSXV:LFST) (FRANKFURT:M5B) has closed a non-brokered private placement of secured convertible debentures for aggregate gross proceeds to the company of CA$225,000 ($166,000).
Radient Closes Second And Final Tranche Of Financing
Radient Technologies Inc. (OTCPK:RDDTF) (TSXV: RTI) , a commercial manufacturer cannabis extracts and packaged products, has closed the second and final tranche of its non-brokered private placement of up to 30 units.
Khiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS Subsidiary
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (FSE:A2JMZC) completed its first phase of business optimization in Colombia, to focus on its high-margin B2C business model, centered around its clinic operations.
Cronos Releases Cannabinoid Life Cycle Study Highlighting Its Sustainable Fermentation Practices
Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) in honor of Earth Day, released a Sustainability Study, which outlines the benefits of using fermentation manufacturing methods for cannabinoid production over the impact of traditional methods of cannabis extraction, which levera
Panacea Life Expands CBD Business Into Guyana, South America
Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH), a Colorado-based manufacturing, research, and product development company in the natural health and wellness industry, announced the execution of a distribution agreement with C.A.G.